To celebrate the launch of the UK’s first CRUK clinical trials unit dedicated to cancer precision prevention in Oxford, join us on Monday 13th of November 2023 for an in-person research symposium highlighting the spectra of Cancer Precision Prevention clinical programmes across the UK.

The aim of the meeting is to:

• Share best practice both in terms of pre-clinical and clinical activity.

• Identify opportunities for novel national and international (US) collaboration.

• Discuss opportunities for developing a national precision prevention clinical platform.

Please note registration will close on Friday 27th October

Agenda:
The day will commence at 08:30 for arrival coffee followed by presentations and a networking lunch,12:30 to 14:00.

Sessions will feature talks on precision prevention research programmes in lung, gynaecological and gastrointestinal cancers and a keynote talk from Dr Eva Szabo, Chief of Lung and Upper Aerodigestive Cancer at the NCI’s Division of Cancer Prevention.

The other confirmed speakers are:

Professor Sarah Blagden (University of Oxford)
Dr David Crosby (Cancer Research UK)
Dr Karin Hellner (University of Oxford)
Professor Ahmed Ahmed (University of Oxford)
Professor Ranjit Manchanda (Queen Mary University of London)
Dr Stephen N Birrell (University of Adelaide)
Dr David Church (University of Oxford)
Bep Dhaliwal (Patient Representative)
Dr Catriona Gilmour Hamilton (University of Oxford)
Dr James Reading (University College London)
Dr Mariam Jamal-Hanjani (University College London)
Professor Daniel Murphy (University of Glasgow)
Professor Kevin Blyth (University of Glasgow)
The prevention team from Cancer Research UK will also be available all day for individual discussions about their recently launched Biology to Prevention funding scheme.

The event will close with a drinks reception at approximately 17:00.